Your browser doesn't support javascript.
loading
COVID-19 in a human T-cell lymphotropic virus type-1 carrier.
Enomoto, Takatoshi; Shiroyama, Takayuki; Hirata, Haruhiko; Amiya, Saori; Adachi, Yuichi; Niitsu, Takayuki; Noda, Yoshimi; Hara, Reina; Fukushima, Kiyoharu; Suga, Yasuhiko; Miyake, Kotaro; Koyama, Shohei; Iwahori, Kota; Nagatomo, Izumi; Tokuhira, Natsuko; Uchiyama, Akinori; Takeda, Yoshito; Kumanogoh, Atsushi.
Afiliação
  • Enomoto T; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Shiroyama T; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Hirata H; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Amiya S; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Adachi Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Niitsu T; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Noda Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Hara R; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Fukushima K; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Suga Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Miyake K; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Koyama S; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Iwahori K; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Nagatomo I; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Tokuhira N; Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan.
  • Uchiyama A; Department of Anesthesiology and Intensive Care Medicine Osaka University Graduate School of Medicine Osaka Japan.
  • Takeda Y; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
  • Kumanogoh A; Department of Respiratory Medicine and Clinical Immunology Osaka University Graduate School of Medicine Osaka Japan.
Clin Case Rep ; 10(2): e05463, 2022 Feb.
Article em En | MEDLINE | ID: mdl-35223018
This is the first report of COVID-19 in a human T-cell lymphotropic virus type-1 (HTLV-1) carrier. HTLV-1 infection can cause immune dysfunction even in asymptomatic carriers. This case highlights the need for guidance on management of COVID-19-HTLV-1 coinfection, specifically on the appropriate use of corticosteroid treatment while considering secondary infection.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2022 Tipo de documento: Article